Quick Takeaways
- Casdin Capital, LLC filed SCHEDULE 13G/A for Relay Therapeutics, Inc. Common Stock, par value $0.001 per share (RLAY).
- Disclosed ownership: 7.5%.
- Date of event: 31 Dec 2025.
Casdin Capital, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Relay Therapeutics, Inc. Common Stock, par value $0.001 per share (RLAY)
- Filing Manager
- Casdin Capital, LLC
- Reporting Manager
- CASDIN CAPITAL, LLC
- Symbol
- RLAY
- Shares outstanding
- 173,380,987 shares
- Disclosed Ownership
- 13,003,574 shares
- Ownership
- 7.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:47:07 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Casdin Capital, LLC disclosed 7.5% ownership in Relay Therapeutics, Inc. Common Stock, par value $0.001 per share (RLAY) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 16:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| CASDIN CAPITAL, LLC | 7.5% | 13,003,574 | 0 | 13,003,574 | By: /s/ Eli Casdin | Eli Casdin, Managing Member | |
| CASDIN PARTNERS MASTER FUND, L.P. | 7.3% | 12,585,000 | 0 | 12,585,000 | By: /s/ Eli Casdin | Eli Casdin, Managing Member of its general partner | |
| CASDIN PARTNERS GP, LLC | 7.5% | 13,003,574 | 0 | 13,003,574 | By: /s/ Eli Casdin | Eli Casdin, Managing Member | |
| ELI CASDIN | 7.5% | 13,003,574 | 0 | 13,003,574 | By: /s/ Eli Casdin | Eli Casdin |